Skip to content
← Research Hub
MetabolismPEM-relevant

Energy Metabolism

203 studies in the atlas

Altered energy metabolism is a candidate mechanism under active investigation in ME/CFS research. Studies report signals suggestive of impaired cellular energy production, altered metabolomics profiles, and elevated oxidative stress markers in patient populations. Metabolomics analyses have identified differences in metabolites associated with the citric acid cycle and amino acid metabolism, though findings are not uniform across cohorts and a specific mitochondrial mechanism has not been established. Cellular energy stress may contribute to the reduced functional capacity seen in ME/CFS; direct mechanistic proof for post-exertional malaise has not been demonstrated.

What we know

  • Naviaux et al. (2016) identified a hypometabolic state in ME/CFS patients using broad metabolomic profiling
  • Multiple independent studies have reported altered metabolite levels, though specific findings vary across cohorts
  • Signals suggestive of impaired cellular energy production have been reported, including reduced oxidative phosphorylation in some studies, but a specific mitochondrial mechanism has not been established
  • Metabolic differences appear to worsen after exertion in several studies, a pattern consistent with PEM

What remains uncertain

  • Whether altered energy metabolism is a primary cause or a consequence of upstream immune or neurological processes
  • Mitochondrial impairment has been proposed and partially supported, but the evidence is heterogeneous and a specific mechanism has not been established
  • The relationship between metabolic findings and specific symptoms is not well mapped
  • Whether metabolic subtypes exist that respond to different interventions

What is emerging

  • Whether metabolomic profiles can serve as diagnostic biomarkers
  • Whether targeted metabolic interventions (e.g., oxaloacetate, NAD+ precursors) have measurable benefit
  • The full extent of metabolic overlap between ME/CFS and Long COVID
  • How metabolic impairment relates to the exercise intolerance demonstrated in CPET studies

Start here

E0 ConsensusPEM requiredModerate confidence

Comparison of serum acylcarnitine levels in patients with myalgic encephalomyelitis/chronic fatigue syndrome and healthy controls: a systematic review and meta-analysis.

Jinushi, Ryuhei, Masuda, Sakue, Tanisaka, Yuki et al.·Journal of translational medicine·2023

This review combined results from seven studies comparing a chemical in the blood called acylcarnitine between people with ME/CFS and healthy people. Researchers found that people with ME/CFS have significantly lower levels of this chemical. These lower levels might one day help doctors diagnose ME/CFS, though more research is needed before it can be used as a reliable test.

Research Momentum

203 publications over 36 years. Recent trend: steady (14/year over the last 3 years).

Top Studies

60 of 203, sorted by review status and evidence level

E0PEM ✓

Insights into the Complex Biological Network Underlying Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

2025 · Moderate
Dudova, Dobrina et al.·International journal of molecular sciences·Review-NarrativeEditor reviewed
E0PEM ?

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease.

2024 · Moderate
Arron, Hayley E et al.·Frontiers in immunology·Review-NarrativeEditor reviewed
E0PEM ✓

Comparison of serum acylcarnitine levels in patients with myalgic encephalomyelitis/chronic fatigue syndrome and healthy controls: a systematic review and meta-analysis.

2023 · Moderate
Jinushi, Ryuhei et al.·Journal of translational medicine·Systematic-ReviewEditor reviewed
E0PEM ✗

Coenzyme Q10: Clinical Applications beyond Cardiovascular Diseases.

2021 · Preliminary
Testai, Lara et al.·Nutrients·Review-NarrativeEditor reviewed
E0PEM ?

A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome.

2021 · Preliminary
Maksoud, Rebekah et al.·Journal of translational medicine·Systematic-ReviewEditor reviewed
E0PEM ✓

[Myalgic encephalomyelitis or chronic fatigue syndrome].

2019 · Moderate
Brinth, Louise et al.·Ugeskrift for laeger·Review-NarrativeEditor reviewed
E0PEM ✗

Myalgic encephalomyelitis/chronic fatigue syndrome: From pathophysiological insights to novel therapeutic opportunities.

2019 · Preliminary
Morris, Gerwyn et al.·Pharmacological research·Review-NarrativeEditor reviewed
E0PEM ?

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Evidence for an autoimmune disease.

2018 · Moderate
Sotzny, Franziska et al.·Autoimmunity reviews·Review-NarrativeEditor reviewed
E0PEM ?

Chronic fatigue syndrome: a personalized integrative medicine approach.

2014 · Preliminary
Brown, Benjamin I·Alternative therapies in health and medicine·Review-NarrativeEditor reviewed
E0PEM ?

Metabolic reprogramming in diabetes and other endocrine and metabolic disorders: exploring the Warburg effect, ketones, and SGLT2 inhibitors.

2026 · Preliminary
Carrera-Bastos, Pedro et al.·Reviews in endocrine & metabolic disorders·Review-NarrativeEditor reviewed
E0PEM ✗

Understanding the kynurenine pathway: A narrative review on its impact across chronic pain conditions.

2024 · Moderate
Hazrati, Ebrahim et al.·Molecular pain·Review-NarrativeEditor reviewed
E0PEM ?

Induced pluripotent stem cells as suitable sensors for fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome.

2021 · Preliminary
Monzón-Nomdedeu, María B et al.·World journal of stem cells·Review-NarrativeEditor reviewed
E0PEM ?

Diagnostic and Pharmacological Potency of Creatine in Post-Viral Fatigue Syndrome.

2021 · Preliminary
Ostojic, Sergej M·Nutrients·Review-NarrativeEditor reviewed
E0PEM ?

Examining clinical similarities between myalgic encephalomyelitis/chronic fatigue syndrome and D-lactic acidosis: a systematic review.

2017 · Preliminary
Wallis, Amy et al.·Journal of translational medicine·Systematic-ReviewEditor reviewed
E0PEM ✗

Pesticides and human chronic diseases: evidences, mechanisms, and perspectives.

2013 · Preliminary
Mostafalou, Sara et al.·Toxicology and applied pharmacology·Review-NarrativeEditor reviewed
E1PEM ?

RESTORE ME: a RCT of oxaloacetate for improving fatigue in patients with myalgic encephalomyelitis/chronic fatigue syndrome.

2024 · Moderate
Cash, Alan et al.·Frontiers in neurology·RCTEditor reviewed
E1PEM ✓

Metabolic features of chronic fatigue syndrome

2016 · n=84 · Moderate
Robert K. Naviaux et al.·Proceedings of the National Academy of Sciences (PNAS)·ObservationalEditor reviewed
E1PEM ✗

Supplementation with Guanidinoacetic Acid in Women with Chronic Fatigue Syndrome.

2016 · Preliminary
Ostojic, Sergej M et al.·Nutrients·RCTEditor reviewed
E1PEM ✗

Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome?

2015 · Moderate
Castro-Marrero, Jesús et al.·Antioxidants & redox signaling·RCTEditor reviewed
E1PEM ✗

Amantadine and L-carnitine treatment of Chronic Fatigue Syndrome.

1997 · Preliminary
Plioplys, A V et al.·Neuropsychobiology·RCTEditor reviewed
E2PEM ?

AI-driven multi-omics modeling of myalgic encephalomyelitis/chronic fatigue syndrome.

2025 · Moderate
Xiong, Ruoyun et al.·Nature medicine·LongitudinalEditor reviewed
E2PEM ?

Circulating Levels of SMPDL3B Define Metabolic Endophenotypes and Subclinical Kidney Alterations in Myalgic Encephalomyelitis.

2025 · Moderate
Rostami-Afshari, Bita et al.·International journal of molecular sciences·Cross-SectionalEditor reviewed
E2PEM ✗

Alterations in gut microbiota and associated metabolites in patients with chronic fatigue syndrome.

2025 · Moderate
Cheng, Xinxin et al.·Scientific reports·Case-ControlEditor reviewed
E2PEM ?

Leveraging Explainable Automated Machine Learning (AutoML) and Metabolomics for Robust Diagnosis and Pathophysiological Insights in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

2025 · Moderate
Yagin, Fatma Hilal et al.·Diagnostics (Basel, Switzerland)·Cross-SectionalEditor reviewed
E2PEM ?

Untargeted Metabolomics and Quantitative Analysis of Tryptophan Metabolites in Myalgic Encephalomyelitis Patients and Healthy Volunteers: A Comparative Study Using High-Resolution Mass Spectrometry.

2024 · Preliminary
Abujrais, Sandy et al.·ACS chemical neuroscience·Cross-SectionalEditor reviewed
E2PEM ✗

Association between fatigue, peripheral serotonin, and L-carnitine in hypothyroidism and in chronic fatigue syndrome.

2024 · Preliminary
Raij, Tommi et al.·Frontiers in endocrinology·ObservationalEditor reviewed
E2PEM ✓

Plasma metabolomics reveals disrupted response and recovery following maximal exercise in myalgic encephalomyelitis/chronic fatigue syndrome.

2022 · Moderate
Germain, Arnaud et al.·JCI insight·ObservationalEditor reviewed
E2PEM ?

A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome.

2021 · Moderate
Hoel, Fredrik et al.·JCI insight·Cross-SectionalEditor reviewed
E2PEM ?

Sex-specific plasma lipid profiles of ME/CFS patients and their association with pain, fatigue, and cognitive symptoms.

2021 · Moderate
Nkiliza, Aurore et al.·Journal of translational medicine·ObservationalEditor reviewed
E2PEM ✗

Metabolic Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Not Due to Anti-mitochondrial Antibodies.

2020 · Moderate
Nilsson, Isabell et al.·Frontiers in medicine·Cross-SectionalEditor reviewed
E2PEM ?

Deep phenotyping of myalgic encephalomyelitis/chronic fatigue syndrome in Japanese population.

2020 · Preliminary
Kitami, Toshimori et al.·Scientific reports·Cross-SectionalEditor reviewed
E2PEM ?

Comprehensive Circulatory Metabolomics in ME/CFS Reveals Disrupted Metabolism of Acyl Lipids and Steroids.

2020 · Preliminary
Germain, Arnaud et al.·Metabolites·Cross-SectionalEditor reviewed
E2PEM ?

Changes in DNA methylation profiles of myalgic encephalomyelitis/chronic fatigue syndrome patients reflect systemic dysfunctions.

2020 · Moderate
Helliwell, A M et al.·Clinical epigenetics·Case-ControlEditor reviewed
E2PEM ✓

Elevated blood lactate in resting conditions correlate with post-exertional malaise severity in patients with Myalgic encephalomyelitis/Chronic fatigue syndrome.

2019 · Moderate
Ghali, Alaa et al.·Scientific reports·Cross-SectionalEditor reviewed
E2PEM ?

MtDNA population variation in Myalgic encephalomyelitis/Chronic fatigue syndrome in two populations: a study of mildly deleterious variants.

2019 · Preliminary
Venter, Marianne et al.·Scientific reports·ObservationalEditor reviewed
E2PEM ?

Low omega-3 index and polyunsaturated fatty acid status in patients with chronic fatigue syndrome/myalgic encephalomyelitis.

2018 · Preliminary
Castro-Marrero, Jesús et al.·Prostaglandins, leukotrienes, and essential fatty acids·Cross-SectionalEditor reviewed
E2PEM ✗

Chronic fatigue syndrome patients have alterations in their oral microbiome composition and function.

2018 · Preliminary
Wang, Taiwu et al.·PloS one·Cross-SectionalEditor reviewed
E2PEM ✗

Higher Prevalence of "Low T3 Syndrome" in Patients With Chronic Fatigue Syndrome: A Case-Control Study.

2018 · Preliminary
Ruiz-Núñez, Begoña et al.·Frontiers in endocrinology·Case-ControlEditor reviewed
E2PEM ?

Evidence of mitochondrial dysfunction and impaired redox signalling in a subgroup of patients with myalgic encephalomyelitis/chronic fatigue syndrome

2017 · n=25 · Preliminary
Cara Tomas et al.·The EPMA Journal·MechanisticEditor reviewed
E2PEM ?

Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism.

2017 · Preliminary
Germain, Arnaud et al.·Molecular bioSystems·Cross-SectionalEditor reviewed
E2PEM ?

Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome.

2017 · Moderate
Nagy-Szakal, Dorottya et al.·Microbiome·Cross-SectionalEditor reviewed
E2PEM ✗

Clinically proven mtDNA mutations are not common in those with chronic fatigue syndrome.

2017 · Moderate
Schoeman, Elizna M et al.·BMC medical genetics·Cross-SectionalEditor reviewed
E2PEM ✗

Genetic evaluation of AMPD1, CPT2, and PGYM metabolic enzymes in patients with chronic fatigue syndrome.

2016 · Weak
Maltese, P E et al.·Genetics and molecular research : GMR·Case-ControlEditor reviewed
E2PEM ✗

Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles.

2016 · Preliminary
Yamano, Emi et al.·Scientific reports·Cross-SectionalEditor reviewed
E2PEM ?

Mitochondrial DNA variants correlate with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome.

2016 · Preliminary
Billing-Ross, Paul et al.·Journal of translational medicine·Case-ControlEditor reviewed
E2PEM ?

Association of mitochondrial DNA variants with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) symptoms.

2016 · Preliminary
Hanson, Maureen R et al.·Journal of translational medicineEditor reviewed
E2PEM ?

Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

2012 · Preliminary
Booth, Norman E et al.·International journal of clinical and experimental medicine·Cross-SectionalEditor reviewed
E2PEM ✗

Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology.

2012 · Moderate
Shungu, Dikoma C et al.·NMR in biomedicine·Cross-SectionalEditor reviewed
E2PEM ✗

The assessment of the energy metabolism in patients with chronic fatigue syndrome by serum fluorescence emission.

2012 · Preliminary
Mikirova, Nina et al.·Alternative therapies in health and medicine·Case-ControlEditor reviewed
E2PEM ✗

Mitochondrial enzymes discriminate between mitochondrial disorders and chronic fatigue syndrome.

2011 · Moderate
Smits, Bart et al.·Mitochondrion·Cross-SectionalEditor reviewed
E2PEM ✗

Long-chain acylcarnitine deficiency in patients with chronic fatigue syndrome. Potential involvement of altered carnitine palmitoyltransferase-I activity.

2011 · Preliminary
Reuter, S E et al.·Journal of internal medicine·Cross-SectionalEditor reviewed
E2PEM ✗

Chronic fatigue syndrome is associated with metabolic syndrome: results from a case-control study in Georgia.

2010 · Moderate
Maloney, Elizabeth M et al.·Metabolism: clinical and experimental·Case-ControlEditor reviewed
E2PEM ✗

Physiological cost of walking in those with chronic fatigue syndrome (CFS): a case-control study.

2009 · Moderate
Paul, Lorna et al.·Disability and rehabilitation·Case-ControlEditor reviewed
E2PEM ✗

Increased d-lactic Acid intestinal bacteria in patients with chronic fatigue syndrome.

2009 · Preliminary
Sheedy, John R et al.·In vivo (Athens, Greece)·Case-ControlEditor reviewed
E2PEM ✗

Chronic fatigue syndrome and mitochondrial dysfunction.

2009 · Preliminary
Myhill, Sarah et al.·International journal of clinical and experimental medicine·Cross-SectionalEditor reviewed
E2PEM ✗

Visible and near-infrared spectral changes in the thumb of patients with chronic fatigue syndrome.

2009 · Preliminary
Sakudo, Akikazu et al.·Clinica chimica acta; international journal of clinical chemistry·Cross-SectionalEditor reviewed
E2PEM ✗

Transcription profile analysis of vastus lateralis muscle from patients with chronic fatigue syndrome.

2009 · Preliminary
Pietrangelo, T et al.·International journal of immunopathology and pharmacology·MechanisticEditor reviewed
E2PEM ✗

Hematologic and urinary excretion anomalies in patients with chronic fatigue syndrome.

2007 · Moderate
Niblett, Suzanne H et al.·Experimental biology and medicine (Maywood, N.J.)·Case-ControlEditor reviewed
E2PEM ✗

Allostatic load is associated with symptoms in chronic fatigue syndrome patients.

2006 · Preliminary
Goertzel, Benjamin N et al.·Pharmacogenomics·Case-ControlEditor reviewed
E2PEM ?

Urinary and plasma organic acids and amino acids in chronic fatigue syndrome.

2005 · Preliminary
Jones, Mark G et al.·Clinica chimica acta; international journal of clinical chemistry·Cross-SectionalEditor reviewed

Contribute

Private, reviewed by a human. Not a public comment thread.